Amgen’s Chances of Recovering from its Woes
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 87 (Table of Contents)
Published: 7 Sep-2007
DOI: 10.3833/pdr.v2007.i87.292 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
There has been a consensus that large biotechs are answerable to different commercial dynamics from large pharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS